某专科医院COVID-19流行前后社区获得性肺炎发生频率和性质比较
- 作者: Yaremenko S.1,2, Rucheva N.1, Zhuravlev K.1, Sinitsyn V.2
-
隶属关系:
- State Moscow Clinical Hospital I.V.Davydovskiy
- Lomonosov Moscow State University
- 期: 卷 1, 编号 1 (2020)
- 页面: 37-47
- 栏目: 原创性科研成果
- URL: https://journals.rcsi.science/DD/article/view/46833
- DOI: https://doi.org/10.17816/DD46833
- ID: 46833
如何引用文章
详细
论证:2019年中国武汉首次报道的2019冠状病毒病(COVID-19)在短短一个月内迅速席卷全球。聚合酶链反应(PCR)方法有助于诊断这种疾病,但这种检测有与假阴性结果,以及截止日期有限制。考虑到感染传播的增加,对胸部器官进行计算机断层扫描(CT)可以成为临床医生用于早期检测COVID-19患者的主要技术之一。
目的是根据莫斯科某专科医院COVID-19流行前和流行期间的CT资料,比较社区获得性肺炎的发生频率及其特征,并探讨其及时发现和鉴别诊断的可能性。
材料与方法。2020年4月1日至4月17日期间对I.V. Davydovsky City Clinical Hospital(莫斯科)患者胸部CT检查结果进行了回顾性分析。本研究纳入所有根据CT诊断为病毒性肺炎的患者。所有疑似病毒性肺炎患者均在住院第一天进行PCR检测。作为对照组,对2019年同期以疑似肺炎入院患者的胸部CT资料进行了回顾性分析。
结果。在2020年4月1日至4月17日期间,根据胸部器官计算机断层扫描,有140例确诊为肺炎,其中65例(46.4%)被描述为病毒性肺炎,与2019年同期相比,7例(10.3%)被诊断为病毒性肺炎:病毒性肺炎病例显著增加(5723例;p < 0.01)。根据计算机断层扫描对病毒性肺炎患者进行PCR检测结果:34例(52.3%)为阳性,22例(33.8%)为阴性,未进行检测9例(13.9%)。比较2019年与2020年同期患者病毒性肺炎型CT检出频次,差异无统计学意义。胸部CT显示COVID-19的概率:平均概率为13.8%,高概率为75.4%。根据胸部CT检查病毒性肺炎的严重程度:轻度—38.5%,中度—46.2%,重度—12.3%,极重度—3.1%。在病毒性肺炎患者组中,根据CT资料,出现以下X线现象:淋巴结病为32.3%,胸水为21.5%,心包水为4.6%,肺动脉高压为21.5%。
结论。已经证明,以研究的相对速度对COVID-19进行CT诊断,并对获得的结果(包括PCR检测假阴性结果)进行解释,可以及时隔离疑似COVID-19患者,及时开始治疗,并防止病毒感染在大流行中进一步传播。然而,由于所检测到的形态学图像的非特异性,CT用特异性病毒制剂鉴别肺病变的可能性有限。
作者简介
Stepan Yaremenko
State Moscow Clinical Hospital I.V.Davydovskiy; Lomonosov Moscow State University
编辑信件的主要联系方式.
Email: yaremenkosa@yandex.ru
ORCID iD: 0000-0002-7709-977X
MD, PhD student
俄罗斯联邦, MoscowNatalia Rucheva
State Moscow Clinical Hospital I.V.Davydovskiy
Email: rna1969@yandex.ru
ORCID iD: 0000-0002-8063-4462
MD, PhD
俄罗斯联邦, MoscowKirill Zhuravlev
State Moscow Clinical Hospital I.V.Davydovskiy
Email: kir232@mail.ru
ORCID iD: 0000-0003-1733-267X
MD
俄罗斯联邦, MoscowValentin Sinitsyn
Lomonosov Moscow State University
Email: vsini@mail.ru
ORCID iD: 0000-0002-5649-2193
MD, PhD, Professor
俄罗斯联邦, Moscow参考
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017
- Xie X, Zhong Z, Zhao W, et al. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology. 2020;296(2):E41−E4. doi: 10.1148/radiol.2020200343
- World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of December 31, 2003). Available from: https://www.who.int/publications/m/item/summary-of-probable-sars-cases-with-onset-of-illness-from-1-november-2002-to-31-july-2003
- World Health Organization. Naming the coronavirus disease (COVID-2019) and the virus that causes it. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
- She J, Jiang J, Ye L, et al. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020;9(1):19. doi: 10.1186/s40169-020-00271-z
- Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–460. doi: 10.1007/s11427-020-1637-5
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
- Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020; 296(2):E115−E117. doi: 10.1148/radiol.2020200432
- Chung M, Bernheim A, Mei X, et al. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020. doi: 10.1148/radiol.2020200230
- BSTI. COVID-19 BSTI reporting templates and Codes. Available from: https://www.bsti.org.uk/covid-19-resources/covid-19-bsti-reporting-templates/
- Paul NS, Roberts H, Butany J, et al. Radiologic pattern of disease in patients with severe acute respiratory syndrome: The Toronto experience. Radiographics. 2004;24:553–563. doi: 10.1148/rg.242035193
- Das KM, Lee EY, Langer RD, Larsson SG. Middle East respiratory syndrome coronavirus: What does a radiologist need to know? AJR Am J Roentgenol. 2016;206(6):1193−1201. doi: 10.2214/AJR.15.15363
- Koo HJ, Lim S, Choe J, et al Radiographic and CT features of viral pneumonia. Radiographics. 2018;38(3):719−739. doi: 10.1148/rg.2018170048
- McGonagle D, Sharif K, O’Regan A, Bridgewood C. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun Rev. 2020;102537. doi: 10.1016/j.autrev.2020.102537
- Colafrancesco S, Priori R, Alessandri C, et al. sCD163 in AOSD : a biomarker for macrophage activation related to hyperferritinemia. Immunol Res. 2014;60(2-3):177−183. doi: 10.1007/s12026-014-8563-7
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934−943. doi: 10.1001/jamainternmed.2020.0994
补充文件
![](/img/style/loading.gif)